Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2008 Jul 14.
Published in final edited form as: J Nat Prod. 2007 Jun 5;70(6):1064–1067. doi: 10.1021/np0701428

Antiproliferative Cardenolides of an Elaeodendron sp. from the Madagascar Rain Forest

Shugeng Cao 1,, Peggy J Brodie 1,, James S Miller 1,, Fidy Ratovoson 1,§, Martin W Callmander 1,§, Sennen Randrianasolo 1,, Etienne Rakotobe 1,, Vincent E Rasamison 1,, Edward M Suh 1,, Karen TenDyke 1,, David G I Kingston 1,†,*
PMCID: PMC2464365  NIHMSID: NIHMS49562  PMID: 17547460

Abstract

Bioassay-guided fractionation of an ethanol extract obtained from the Madagascar plant Elaeodendron sp. led to the isolation of two new cardenolides, elaeodendrosides T and U (1 and 2). The structures of the new compounds were elucidated using 1D and 2D NMR experiments, and mass spectrometry. Compounds 1, 3, 4, and 5 showed significant antiproliferative activity against A2780 human ovarian cancer cells with IC50 values of 0.085, 0.019, 0.19, and 0.10 µM, respectively, while compounds 2 and 6 were less active.


In our continuing search for bioactive molecules from the Madagascar rainforests as part of an International Cooperative Biodiversity Group (ICBG) program,1 we obtained an EtOH extract of the wood of Elaeodendron sp. (Celastraceae). This extract (MG 3232) showed antiproliferative activity against the A2780 ovarian cancer cell line with an IC50 value of 7.6 µg/mL. The extract was selected for bioassay-guided fractionation based on its activity, and also on the absence of any previous chemical investigation of the species.

There are ca. forty species in the genus Elaeodendron from the Mexican coast, Bermuda, Africa, Madagascar (incl. Mascarene), India, Melanesia, and Australia.2 The plants in this genus are usually glabrous trees or shrubs,2 and flavonoids,3 terpenoids,4 and cardenolides5 have been isolated from them. Cardenolides are also prominent cardioactive secondary metabolites of many medicinal plants belonging to the Apocynaceae (Nerium, Strophanthus, Thevetia), Asclepiadaceae (Periploca, Calotropis, Xysmalobium), Scrophulariaceae (Digitalis), Ranunculaceae (Adonis), and Convallariaceae families (Convallaria, Speirantha).6 The cytotoxicity of cardenolides as well as their cardiac activity have been widely studied.7

An EtOH extract of the woods (MG 3232) of Elaeodendron sp. was subjected to liquid-liquid partitioning to give an active CH2Cl2 fraction with an IC50 value of 0.3 µg/mL in the A2780 assay. Activity-guided separation of this fraction by passage over a C18 SPE column yielded three subfractions, and subjection of the active second subfraction to further purification using C18 HPLC led to the isolation of the two new compounds 1 and 2, and the four known compounds elaeodendroside B (3),5f elaeodendroside F (4),5f elaeodendroside G (5),5f and (2α,3β,14β)-trihydroxy-3-O-(4-deoxy-3-O-methyl-α-L-erythro-pentopyranosyl)-card-4,20(22)-dienolide (6).5g Here we report the structures of the two new compounds elaeodendroside T (1) and U (2) as well as the antiproliferative activity of all the isolates.

Compound 1 was obtained as a white powder. Its HRFABMS (positive-ion mode) exhibited a quasimolecular ion peak at m/z 589.2962, consistent with a molecular composition of C32H45O10 (calcd 589.3013). The 13C NMR spectrum of compound 1 contained 32 signals, which were assigned to one methoxy, one acetoxy, three methyls, eight methylenes, eleven methines, and eight quaternary carbons based on its 1H NMR and HSQC spectra. The 1H and 13C NMR signals (C6D6, Table 1) at δC 170.3 (C-20), δCH 73.3 (C-21)/4.71 and 4.56 (both as br d, J = 17.9 Hz, H2-21), δCH 119.0 (C22)/5.85 (br s, H22), and δC 173.4 (C23), indicated the presence of an α,β-unsaturated γ-lactone unit. The spin systems in ring A (H2-1 through H-2 and H-3 to H-4: CH2—CH—CH—CH), rings B and C (H2-6 through H2-7, H-8, H-9, and H2-11 to H2-12: CH2—CH2—CH—CH—CH2—CH2), and ring D (H2-15 through H-16 to H-17: CH2—CH—CH) of the aglycone were identified from the COSY and TOSCY spectra. The aglycone of 1 was established as a 2,3,14,16-tetraoxygenated card-4,20(22)-dienolide based on its HMBC correlations (Fig. 1). The acetoxy group attached to C-16 was detected by HMBC correlations from both H-16 (δH 5.15, ddd, J = 11.3, 7.7, 4.1 Hz) and the methyl protons of the acetyl group (δH 1.70, s) to the carbonyl carbon at δC169.8. H-3 showed a ROESY correlation (Fig. 2) to Hα-1 (axial-like), and H-2 exhibited ROESY correlations to H3-19 and Hβ-1 (equatorial-like), indicating a trans relationship between H-3 and H-2. The trans and cis fusions for the rings B/C and C/D were established by the ROESY correlations from Hα-1 (axial-like) to H-9, from H-15 to H-7, and from both H3-18 and H3-19 to Hβ-11 (axial) and H-8, separately. The ROESY spectrum of 1 also revealed crosspeaks from H-17 to H-21, H-22, and H-16, and from H3-18 to H-21 and H-22; the substituents at 13-, 16-, and 17-positions were therefore designated β. The multiplicities and coupling constants of the protons in the sugar moiety were deduced from the 1H NMR spectrum as follows: H-1′ showed a singlet at δ 5.04; H-3′ appeared as a broad singlet at δ 3.29; H2-4′ resonated as two multiplets at δ 1.53 and 1.80; H-5′ appeared as a multiplet at δ 3.90; H3-6′ resonated as a doublet at δ 1.22 (J = 5.2 Hz) while the 3′-OMe resonated at δ 2.90 as a singlet. The connectivity of protons in ring A' (H-3′ through H2-4′ and H-5′, to H3-6′: CH—CH2—CH—CH3) was confirmed by the COSY and TOCSY spectra. ROESY correlations from H-1′ to 2′-OH (δ 3.61), and from H-5′ to H-1′ and 3′-OMe indicated that the sugar moiety was a 2′-oxygenated 4′,6′-dideoxy-3′-O-methyl-allopyranoside. The connectivity between C-1′ and C-3 through an oxygen bridge was confirmed by the observation of an HMBC correlation from H-1′ to C-3.

Table 1.

1Ha and 13Cb NMR Data of Compounds 1 and 2

no. 1H 13C

1c 2c 1c 1d 2d
1 1.32 t (12.7), 1.75 m 1.28 m, 1.90 m 41.6 40.5 42.9
2 4.54 m 3.90 m 68.9 66.1 67.3
3 4.99 d (8.8) 3.90 m 70.7 69.1 79.7
4 5.45 s 5.25 s 119.3 117.2 119.0
5 145.3 145.4 145.0
6 1.85 m 1.80 br t (10.0), 1.90 m 31.4 30.5 30.6
7 0.60 m, 1.54 m 0.68 m, 1.50, m 28.6 28.0 28.3
8 1.00 m 1.25 m 41.2 40.0 40.0
9 0.70 m 0.90 m 50.4 48.9 46.5
10 40.6 40.0 40.0
11 0.85 m, 1.00 m 1.90 m, 2.15 dd (3.9, 13.7) 21.2 20.4 36.8
12 1.00 m, 1.20 m 39.6 39.0 211.5
13 48.6 48.3 63.7
14 84.2 82.7 84.5
15 1.75 m, 1.82 m 0.80 dd (9.9, 12.0), 0.90 dd (7.7, 12.0) 39.6 39.0 31.7
16 5.15 ddd (11.3, 7.7, 4.1) 1.28 m, 1.50 m 78.7 77.8 26.2
17 2.34 d (3.9) 3.97 dd (8.6, 9.4) 57.9 56.5 40.0
18 0.45 s 0.48 s 15.4 15.0 16.1
19 0.75 s 0.64 s 19.8 19.4 18.8
20 170.3 172.6 173.7
21 4.71 br d (17.9) 4.39 d (17.9) 73.3 73.0 73.3
4.56 br d (17.9) 4.27 d (17.9)
22 5.85 br s 5.79 br s 119.0 116.4 117.1
23 173.4 173.2 175.2
1′ 5.04 s 4.65 d (3.3) 96.7 94.0 98.3
2′ 3.60 ddd (3.3, 4.4, 9.4) 91.0 90.1 66.7
3′ 3.29 br s 3.03 m 80.9 79.3 77.4
4′ 1.53 m, 1.80 m 1.15 m, 1.50 m 33.6 33.4 25.5
5′ 3.90 m 3.05 m, 3.90 m 66.0 64.8 60.5
6′ 1.22 d (5.2) 21.3 20.4
2-OH 4.54 s
14-OH 6.13 s
2′-OH 3.61 s 2.65 d (9.4)
OCH3 2.90 s 2.94 s 57.2 57.2 54.8
OCOCH3 169.8 169.8
OCOCH3 1.70 s 20.5 20.3
a

δ (ppm) 500 MHz; multiplicities; J values (Hz) in parentheses.

b

δ (ppm) 125 MHz.

c

in C6D6.

d

in DMSO-d6.

Figure 1.

Figure 1

Key HMBC correlations of 1

Figure 2.

Figure 2

Key ROESY correlations of 1

In order to determine the orientation of the hydroxyl groups at the 14- and 2′-positions, NMR data were collected in DMSO-d6 (1H NMR data, Experimental Section; 13C NMR data, Table 1). The 14-OH proton (δH 4.59, s) showed ROESY correlations to H-18 (δH 0.78, s), H-8 (δH 1.57), and H-15 (δH 2.06), which confirmed a cis fusion of rings C/D. ROESY correlations from 2′-OH (δH 6.12, s) to H-1′ (δH 4.54, s), H-3′ (δH 3.15, br s), and H-2 (δH 4.06, ddd, J = 2.8, 8.5, 12.1 Hz) supported the presence of another oxygen bridge from C-2′ to C-2, which formed a 1,4-dioxane ring in the chair conformation between rings A and A'. Furthermore, the 13C NMR chemical shifts of the carbons in rings A', A and B of 1 were close to those of affinoside F (7),8 while the carbons in rings C, D, and E had similar chemical shifts to those of cryptostigmin II (8).9 The structure of 1 was thus established as indicated; it was given the trivial name elaeodendroside T.

Compound 2 was also obtained as a white powder. The molecular formula C29H40O9 of 2 was deduced from its HRFABMS. Its 1H NMR spectral data (C6D6, Table 1) showed signals for a cardenolide framework, with methylene protons at δH 4.27 and 4.39 (H2-21, d each, J = 17.9 Hz), an olefinic proton at δH 5.79 (H-22, br s) and a methine proton at δH 3.97 (H-17, dd, J = 8.6, 9.4 Hz). The methyl doublet and acetyl methyl present in 1 were absent in the 1H NMR spectrum of 2. The 13C NMR (DMSO-d6, Table 1) spectrum exhibited 29 signals comprised of one methoxy, two methyls, nine methylenes, ten methines, and seven quaternary carbons, which were assigned from its HSQC spectrum. The HMBC spectrum of 2 (Fig. 3) showed key correlations which established the location of the carbonyl group at C-12 and the sugar at C-3. The aglycone of 2 was thus established as a 2,3,14-trioxygenated 12-oxo-card-4,20(22)-dienolide, which was the same as that of elaeodendroside R.5h The orientation of H-2 (β, axial-like) and H-3 (α, axial-like) of 2 were the same as those of 1 because H-2 (δH 3.90) and H-3 (δH 3.90) showed ROESY (Fig. 4) correlations to H3-19 (δH 0.64) and 2-OH (δH 4.54), respectively (C6D6, Table 1), which was also supported by the multiplicity of H-3 (δH 3.92, d, J = 8.0 Hz) in DMSO-d6 (Experimental Section). The COSY and TOCSY data for 2 identified a connectivity sequence indicative of a coupling system in the sugar moiety (H-1′ through H-2′, H-3′, and H2-4′, to H2-5′: CH—CH—CH—CH2—CH2). A small coupling constant of H-1′ at δH 4.65 (d, J = 3.3 Hz, C6D6, Table 1) indicated that H2′ was equatorial. ROESY crosspeaks from H-1′ to H-3′, and from H-2′ to H-3′ and 3′-OMe suggested H-3′ was axial. These considerations established the structure of 2 as indicated, and it was given the trivial name elaeodendroside U.

Figure 3.

Figure 3

Key HMBC correlations of 2

Figure 4.

Figure 4

Key ROESY correlations of 2

Compounds 1–6 were tested for antiproliferative activity against the A2780 human ovarian cancer cell line, and the two most active compounds 1 and 3 were also evaluated against four additional cell lines. The results are shown in Table 2. The assay results demonstrate that the 1,4-dioxane rings between rings A and A' in compounds 1, 3, 4, and 5 are important for their antiproliferative activity, since compounds 2 and 6 lacking this structural feature are significantly less active than the compounds with this feature.

Table 2.

Antiproliferative Activity of Compounds 16

compound antiproliferative activity (IC50 against the indicated cell line, µM)
A2780a MDA-MB-435b HT-29b H522-T1 U937b
1 0.085 0.37 0.18 0.18c 0.15
2 30 ND ND ND ND
3 0.019 0.15 0.08 0.08b 0.05
4 0.19 ND ND ND ND
5 0.10 ND ND ND ND
6 2.5 ND ND ND ND
a

Average of three determinations

b

Average of two determinations

c

Single determination

Experimental Section

General Experimental Procedures

Optical rotations were recorded on a Perkin-Elmer 241 polarimeter. IR spectra were measured on a MIDAC M-series FTIR spectrophotometer. NMR spectra were obtained on a JEOL Eclipse 500 and an Inova 400 spectrometer. The chemical shifts are given in δ (ppm), and coupling constants are reported in Hz. Mass spectra were obtained on a JEOL JMS-HX-110 instrument, in the positive ion mode. HPLC was performed on a Shimadzu LC-10AT instrument with a semi-preparative C8 Varian Dynamax column (5 µm, 250 × 10 mm) and a preparative C18 Varian Dynamax column (8 µm, 250 × 21.4 mm).

Antiproliferative Activity

Determinations of antiproliferative activities were performed at Virginia Polytechnic Institute and State University against the A2780 ovarian cancer cell line as previously described.10 The A2780 cell line is a drug - sensitive human ovarian cancer cell line.11 Antiproliferative effects of compounds on the four cultured human cancer cell lines MDA-MB-435 breast cancer, HT-29 colon cancer, H522-T1 non-small cell cancer, and U937 histiocytic lymphoma were performed at Eisai Research Institute as previously described,12 with the exception that luminescence was read on an Envision 2102 Multilabel Reader.

Plant Material

Wood of the tree Elaeodendron sp. (Celastraceae) was collected in the Montagne des Français region, a dry forest on limestone, Antsiranana, Madagascar, at elevation: 220 m, at 12.24.42 S, 49.22.22 E, on February 14, 2005. The tree was 14 m high with diameter at breast height of 55 cm, growing on a boulder near a stream, and it yellow petioles, red bark, red wood, gray stem, and immature green fruit. It was determined by R. H. Archer (South African National Biodiversity Institute) in 2007 as a new species; its assigned collector number is Randrianasolo.S (SSR) 520. The species of Elaeodendron collected in Madagascar is different from E. orientale Jacq., the type of the genus, known only from the Mascarene Islands. It has similar leaves, but the fruit is much smaller with sharp points at both ends. In addition, juvenile leaves are conspicuously long and narrow. The vernacular of the new species is tangenala. Species of Cerbera (Apocynaceae) with the same vernacular name were formerly used for the ordeal by poison practice in Madagascar. Nothing is known about the uses of Elaeodendron except that the fruit is reported to be toxic to lemurs. Voucher specimens have been deposited at herbaria of: the Centre National d'Application des Recherches Pharmaceutiques, Madagascar (CNARP); the Parc Botanique et Zoologique de Tsimbazaza, Madagascar (TAN); at the Missouri Botanical Garden, St. Louis, Missouri (MO); and at the Muséum National d'Histoires Naturelles, Paris, France (P).

Extraction and Isolation

Dried wood of Elaeodendon sp. (250 g) were ground in a hammer mill, then extracted with EtOH by percolation for 24 h at rt to give the crude extract MG 3232 (15.9 g), of which 5.0 g was shipped to Virginia Polytechnic Institute and State University (VPISU) for fractionation. MG 3232 (1.5 g) was suspended in aqueous MeOH (MeOH-H2O, 9:1, 150 mL) and extracted with hexanes (3 × 150 mL portions). The aqueous layer was then diluted to 70% MeOH (v/v) with H2O and extracted with CH2Cl2 (3 × 160 mL portions). The CH2Cl2 extract was evaporated in vacuo to leave a 128.8 mg of residue (IC50: 0.3 µg/mL). Both the hexane and aqueous MeOH extracts (40.3 mg and 1.3 g) were inactive. The CH2Cl2 extract was treated with C18 SPE eluting with 50%, then 100% MeOH-H2O, and 5% CH2Cl2-MeOH to furnish three fractions (I–III: 25, 100, and 3 mg, respectively). Only fraction II was active with an IC50 value of 0.3 µg/mL, and this fraction was loaded on a C18 Varian Dynamax HPLC column [8 µm, 250 × 21.4 mm, 10 mL/min (0 min, 18 min, 40 min; 50%, 56%, 100% MeOH-H2O)], and thirteen subfractions (A-M) were collected. Subfractions J, K and L yielded compounds 5 (3 mg, tR 35.5 min), 6 (1 mg, tR 38.5 min) and 1 (2 mg, tR 49 min), respectively. Purification of subfraction E was carried out by C8 HPLC with 45% MeOH-H2O as an eluent to yield 2 (0.5 mg, tR 24 min). Subfraction H yielded compound 3 (1.2 mg, Rf0.30) and compound 4 (1.1 mg, Rf0.35) after separation over preparative Si gel TLC developed with CH2Cl2-MeOH (20:1).

Elaeodendroside T. (1)

white powder; [α]D23 +12 (c 0.05, MeOH); UV (MeOH) λmax (log ε) 218 (4.39) nm; IR (film) νmax 3430, 2930, 1733, 1448, 1373, 1242, 1091, 1027 cm−1; 1H NMR (500 MHz, DMSO-d6): 0.78 (3H, s, H318), 0.87 (1H, t, J = 12.1 Hz, H7a), 1.04 (3H, s, H319), 1.11 (3H, d, J = 5.0 Hz, H36′), 1.19 (1H, t, J = 11.3 Hz, H9), 1.23 (1H, t, J = 13.0 Hz, H11a), 1.38 (1H, dd, J = 12.1, 12.4 Hz, H1a), 1.50 (1H, m, H11b), 1.55 (1H, m, H4a'), 1.57 (1H, m, H8), 1.58 (1H, m, H12a), 1.61 (1H, dd, J = 2.8, 12.4 Hz, H1b), 1.75 (1H, dd, J = 2.0, 13.8 Hz, H4b'), 1.98 (3H, s, 16-OAc), 2.06 (2H, m, H26), 2.06 (1H, m, H7b), 2.06 (1H, m, H12b), 2.06 (2H, m, H215), 2.68 (1H, d, J = 3.8 Hz, H17), 3.15 (1H, br s, H3′), 3.83 (1H, m, H5′), 4.06 (1H, ddd, J = 2.8, 8.5, 12.1 Hz, H2), 4.37 (1H, d, J = 8.5 Hz, H3), 4.54 (1H, s, H1′), 4.59 (1H, s, 14-OH), 4.89 (2H, br s, H221), 5.08 (1H, br s, H4), 5.14 (1H, ddd, J = 3.8, 8.0, 12.1 Hz, H16), 5.98(1H, s, H22), 6.12 (1H, s, 2′-OH); 1H NMR (500 MHz, C6D6) and 13C NMR (125 MHz, C6D6 and DMSO-d6) see Table 1; HRFABMS m/z 589.2962 (calcd for C32H45O10, 589.3013).

Elaeodendroside U. (2)

white powder; [α]D23 -9 (c 0.11, MeOH); UV (MeOH) λmax (log ε) 220 (4.01) nm; IR (film) νmax 3434, 2938, 1736, 1445, 1370, 1240, 1067cm−1; 1H NMR (500 MHz, DMSO-d6): 0.98 (3H, s, H318), 1.08 (3H, s, H319), 3.24 (3H, s, 3′-OMe), 3.30 (1H, m, H3′), 3.35 (1H, m, H5a'), 3.53 (1H, m, H2), 3.79 (1H, br s, H2′), 3.86 (1H, m, H5b'), 3.92 (1H, d, J = 8.0 Hz, H3), 3.99 (1H, dd, J = 8.0, 8.3 Hz, H17), 4.45 (1H, s, H1′), 4.90 (2H, br s, H221), 5.25 (1H, s, H4), 5.96 (1H, s, H22); 1H NMR (500 MHz, C6D6) and 13C NMR (125 MHz, DMSO-d6) see Table 1; HRFABMS m/z 555.2528 (calcd for C29H40O9Na, 555.2570).

Supplementary Material

1

graphic file with name nihms49562f5.jpg

Acknowledgment

This project was supported by the Fogarty International Center, the National Cancer Institute, the National Science Foundation, the National Heart, Lung and Blood Institute, the National Institute of Mental Health, the Office of Dietary Supplements, and the Office of the Director of NIH, under Cooperative Agreement U01 TW 00313 with the International Cooperative Biodiversity Groups, and this support is gratefully acknowledged. We thank Mr. B. Bebout for obtaining the mass spectra, Mr. T. Glass for assistance with the NMR spectra and Dr. R. H. Archer at the National Herbarium, South African National Biodiversity Institute, Pretoria for data on the genus Elaeodendron. Field work essential for this project was conducted under a collaborative agreement between the Missouri Botanical Garden and the Parc Botanique et Zoologique de Tsimbazaza and a multilateral agreement between the ICBG partners, including the Centre National d’Applications des Recherches Pharmaceutiques. We gratefully acknowledge courtesies extended by the Government of Madagascar (Ministère des Eaux et Forêts).

Footnotes

Supporting Information Available: 1H and 13C NMR spectra of compounds 1 and 2. This material is available free of charge via the Internet at http://pubs.acs.org.

References and Notes

  • 1.Biodiversity Conservation and Drug Discovery in Madagascar, Part 28. For Part 27, see: Cao S, Brodie PJ, Miller JS, Ratovoson F, Birkinshaw C, Randrianasolo S, Rakotobe E, Rasamison VE, Kingston DGI. J. Nat. Prod. 2007 doi: 10.1021/np070004i.
  • 2.(a) Archer RH, Van Wyk AE. S. Afr. J. Bot. 1998;64:93–109. [Google Scholar]; (b) Islam MB, Simmons MP, Archer RH. Syst. Bot. 2006;31:512–524. [Google Scholar]
  • 3.(a) Weeratunga G, Bohlin L, Sandberg F, Kumar V. Acta Pharm. Suecica. 1984;21:73–76. [PubMed] [Google Scholar]; (b) Weeratunga G, Bohlin L, Verpoorte R, Kumar V. Phytochemistry. 1985;24:2093–2095. [Google Scholar]
  • 4.(a) Anjaneyulu ASR, Narayana Rao M. Phytochemistry. 1980;19:1163–1169. [Google Scholar]; (b) Weeratunga G, Kumar V, Sultanbawa MUS, Balasubramaniam S. J. Chem. Soc., Perkin Trans. 1: Org. Bioorg. Chem. 1982:2457–2459. [Google Scholar]; (c) Weeratunga G, Kumar V, Sultanbawa MUS. Tetrahedron Lett. 1982;23:2031–2032. [Google Scholar]; (d) Weeratunga G, Kumar V, Sultanbawa MUS. Aust. J. Chem. 1983;36:1067–1072. [Google Scholar]; (e) Weeratunga G, Kumar V. Phytochemistry. 1985;24:2369–2372. [Google Scholar]; (f) Kubo I, Fukuhara K. J. Nat. Prod. 1990;53:968–971. [Google Scholar]; (g) Tsanuo MK, Hassanali A, Jondiko IJO, Torto B. Phytochemistry. 1993;34:665–667. [Google Scholar]
  • 5.(a) Kupchan SM, Uchida I, Shimada K, Fei BY, Stevens DM, Sneden AT, Miller RW, Bryan RF. J. Chem. Soc. Chem. Comm. 1977:255–256. [Google Scholar]; (b) Shimada K, Nambara T, Uchida I, Kupchan SM. Heterocycles. 1979;12:1445–1448. [Google Scholar]; (c) Anjaneyulu ASR, Rao MN. Indian J. Chem., Sect B. 1980;19B:944–949. [Google Scholar]; (d) Shimada K, Kyuno T, Nambara T, Uchida I. Heterocycles. 1981;15:355–360. [Google Scholar]; (e) Shimada K, Kyuno T, Nambara T, Uchida I. Chem. Pharm. Bull. 1982;30:4075–4081. doi: 10.1248/cpb.30.4075. [DOI] [PubMed] [Google Scholar]; (f) Shimada K, Kyuno T, Nambara T, Uchida I. Phytochemistry. 1985;24:1345–1350. [Google Scholar]; (g) Shimada K, Ishii N, Ohishi K, Ro JS, Nambara T. J. Pharmacobio-Dyn. 1986;9:755–759. doi: 10.1248/bpb1978.9.755. [DOI] [PubMed] [Google Scholar]; (h) Shimada K, Masuda H, Ohtaki H, Kobayashi N, Nambara T. Heterocycles. 1990;30:441–450. [Google Scholar]; (i) Tsujino Y, Ogoche JIJ, Tazaki H, Fujimori T, Mori K. Phytochemistry. 1995;40:753–756. [Google Scholar]; (j) Kasai HF, Kawai K, Shimada K. Heterocycles. 2000;53:2689–2700. [Google Scholar]
  • 6.Pauli GF, Matthiesen U, Fronczek FR. Phytochemistry. 1999;52:1075–1084. [Google Scholar]
  • 7.(a) Hoffmann JJ, Cole JR. J. Pharm. Sci. 1977;66:1336–1338. doi: 10.1002/jps.2600660935. [DOI] [PubMed] [Google Scholar]; (b) Hembree JA, Chang CJ, McLaughlin JL, Peck G, Cassady JM. J. Nat. Prod. 1979;42:293–298. [Google Scholar]; (c) Koike K, Bevelle C, Talapatra SK, Cordell GA, Farnsworth NR. Chem. Pharm. Bull. 1980;28:401–405. doi: 10.1248/cpb.28.401. [DOI] [PubMed] [Google Scholar]; (d) Wagner H, Habermeier H, Schulten HR. Helv. Chim. Acta. 1984;67:54–64. [Google Scholar]; (e) Kamano Y, Sato N, Nakayoshi H, Pettit GR, Smith CR. Chem. Pharm. Bull. 1988;36:326–332. doi: 10.1248/cpb.36.326. [DOI] [PubMed] [Google Scholar]; (f) Kaneda N, Chai H, Pezzuto JM, Kinghorn AD, Farnsworth NR, Tuchinda P, Udchachon J, Santisuk T, Reutrakul V. Planta Med. 1992;58:429–431. doi: 10.1055/s-2006-961506. [DOI] [PubMed] [Google Scholar]; (g) Baek NI, Lee YH, Park JD, Kim SI, Ahn BZ. Planta Med. 1994;60:26–29. doi: 10.1055/s-2006-959401. [DOI] [PubMed] [Google Scholar]; (h) Decosterd L, Gustafson KR, Cardellina JH, II, Cragg GM, Boyd MR. Phytotherapy Res. 1994;8:74–77. [Google Scholar]; (i) Gil RR, Lin L-Z, Chai H-B, Pezzuto JM, Cordell GA. J. Nat. Prod. 1995;58:848–856. doi: 10.1021/np50120a005. [DOI] [PubMed] [Google Scholar]; (j) Kitanaka S, Takido M, Mizoue K, Nakaike S. Chem. Pharm. Bull. 1996;44:615–617. doi: 10.1248/cpb.44.615. [DOI] [PubMed] [Google Scholar]; (k) Kiuchi F, Fukao Y, Maruyama T, Obata T, Tanaka M, Sasaki T, Mikage M, Haque ME, Tsuda Y. Chem. Pharm. Bull. 1998;46:528–530. doi: 10.1248/cpb.46.528. [DOI] [PubMed] [Google Scholar]; (l) Ankli A, Heilmann J, Heinrich M, Sticher O. Phytochemistry. 2000;54:531–537. doi: 10.1016/s0031-9422(00)00144-8. [DOI] [PubMed] [Google Scholar]; (m) Laphookhieo S, Cheenpracha S, Karalai C, Chantrapromma S, Rat-a-pa Y, Ponglimanont C, Chantrapromma K. Phytochemistry. 2004;65:507–510. doi: 10.1016/j.phytochem.2003.10.019. [DOI] [PubMed] [Google Scholar]; (n) Cheenpracha S, Karalai C, Rat-a-Pa Y, Ponglimanont C, Chantrapromma K. Chem. Pharm. Bull. 2004;52:1023–1025. doi: 10.1248/cpb.52.1023. [DOI] [PubMed] [Google Scholar]; (o) Roy MC, Chang F-R, Huang H-C, Chiang MY-N, Wu Y-C. J. Nat. Prod. 2005;68:1494–1499. doi: 10.1021/np0501740. [DOI] [PubMed] [Google Scholar]; (p) Lhinhatrakool T, Sutthivaiyakit S. J. Nat. Prod. 2006;69:1249–1251. doi: 10.1021/np060249f. [DOI] [PubMed] [Google Scholar]
  • 8.Hanada R, Abe F, Mori Y, Yamauchi T. Phytochemistry. 1992;31:3547–3551. [Google Scholar]
  • 9.Kamel MS, Assaf MH, Abe Y, Ohtani K, Kasai R, Yamasaki K. Phytochemistry. 2001;58:537–542. doi: 10.1016/s0031-9422(01)00297-7. [DOI] [PubMed] [Google Scholar]
  • 10.Cao S, Brodie PJ, Randrianaivo R, Ratovoson F, Callmander M, Andriantsiferana R, Rasamison VE, Kingston DGI. J. Nat. Prod. doi: 10.1021/np060627g. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Louie KG, Behrens BC, Kinsella TJ, Hamilton TC, Grotzinger KR, McKoy WM, Winker MA, Ozols RF. Cancer Res. 1985;45:2110–2115. [PubMed] [Google Scholar]
  • 12.Cao S, Norris A, Miller JS, Ratovoson F, Razafitsalama J, Andriantsiferana R, Rasamison VE, TenDyke K, Suh T, Kingston DGI. J. Nat. Prod. 2007;70:361–366. doi: 10.1021/np060506g. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES